Cardiorenal Collaboration: Optimizing Multidisciplinary Care in the CvRM Patient
Raymond Townsend, MD
Melissa Magwire, RN, MSN, CDE
Michael Weber, MD
More Screening Recommendations? These Could Save Your Patient's Life
Tessa Janovsky, PA-C
Endocrinologists and PCPs: The Frontline Defense Against Cirrhosis in Patients with Type 2 Diabetes
Jeff McIntyre
Naim Alkhouri, MD, FAASLD, DABOM
Robert H. Eckel, MD, FAHA, FACC, FNLA
I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis
You Want Me to Perform a Liver Stiffness Test in My Clinic, Did I Hear That Right?
Treating Patients With T2D and MASLD: Is the Tide Changing?
It All Starts With a Patient
Noninvasive Tests for Clinically Significant Fibrosis: That's The Hepatologist's Job, Right?
My Patient's At 'Low Risk' for Clinically Significant Fibrosis: What Should I Do Now?
MASLD in My Clinic: Hiding in Plain Sight?
M3: Managing the Cardiometabolic Risk in MASH
Overcoming Clinical Inertia in Hyperkalemia Management
Peter Rossing, MD, DMSc
Michael Böhm, MD, FESC
Luca De Nicola, MD, PhD